Otsuka, Click ‘Digital Therapeutic’ Alliance Aims At Novel Depression Option

“There’s an app for that” could take on added significance under a new alliance for a digital therapeutic for the treatment of depression, in which the partners hope the novel approach will take its place as an effective option among current drug and other cognitive therapies.

Smartphone
Otsuka Teams With Click On Digital Approach To Depression • Source: Shutterstock

Otsuka Pharmaceutical Co. Ltd.’s new alliance with US venture Click Therapeutics Inc. is aimed at developing and commercializing a novel prescription “digital therapeutic” for major depressive disorder, as part of the Japanese firm’s ongoing foray into digital health approaches and strategic focus on the mental health area.

The main goal is to provide an effective new tool to support the management of the highly debilitating condition, one...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Drug Pricing

More from Scrip